Merck stops trial of Alzheimer's drug

Merck stops their Alzheimer's drug trial due to "no chance of finding a positive clinical effect." CNBC's Meg Tirrell reports. The “Fast Money” traders weigh in.
03:02
Tue, Feb 14 20175:22 PM EST